- In full:
- Francis Sellers Collins
- Subjects Of Study:
- cystic fibrosis
- genome
- human genome
- neurofibromatosis
- Role In:
- Human Genome Project
- On the Web:
- NPR - Bridging The Divide: A Scientist's Search For Faith And Truth (Nov. 01, 2026)
Francis Collins
-
Who is Francis Collins?
Francis Collins, born April 14, 1950, is an American geneticist renowned for his work on genes related to genetic diseases and for leading the National Institutes of Health (NIH) as director from 2009 to 2021. Before that, he headed the NIH’s National Human Genome Research Institute (NHGRI) from 1993 to 2008, playing a key role in the Human Genome Project (HGP).
Collins's early achievements include the discovery of the genes responsible for cystic fibrosis in 1989 and neurofibromatosis in 1990. In 2000, he collaborated with J. Craig Venter to announce the completion of a rough draft of the human DNA sequence genetic map. A Christian, Collins has also written books such as The Language of God: A Scientist Presents Evidence for Belief (2006).
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What does a geneticist do?
A geneticist studies heredity, genes, and genetic variation in organisms. Some specialize in human genetics, understanding and treating genetic diseases through lab research into gene function, malfunction, and potential treatments. Model organisms like bacteria and fruit flies often provide insights.
Francis Collins is an American geneticist known for discovering genes causing genetic diseases. He led the National Human Genome Research Institute and contributed to the Human Genome Project, which mapped human DNA. Collins also cautioned against misuse of genetic information and explored the ethical implications of genetic research.
3 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What is Francis Collins known for in science?
Francis Collins is an American geneticist known for his work in discovering genes that cause genetic diseases. In 1989, he announced the discovery of the gene that causes cystic fibrosis. The following year, a Collins-led team found the gene that causes neurofibromatosis, a genetic disorder that generates the growth of tumors. He also served as a leading researcher in a collaboration of six laboratories that in 1993 uncovered the gene that causes Huntington chorea, a neurological disease.
Collins was the director of the U.S. National Institutes of Health (NIH) from 2009 to 2021 and the head of the NIH’s National Human Genome Research Institute (NHGRI) from 1993 to 2008. In this role, Collins led the Human Genome Project (HGP), a public research consortium. On June 26, 2000, Collins and J. Craig Venter announced that the rough draft sequence of the DNA in the human genetic map had been completed through the combined effort of Collins’s public research consortium and Venter’s private company.
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What was Francis Collins’ role in the Human Genome Project?
Francis Collins directed the National Human Genome Research Institute (NHGRI) at the NIH from 1993 to 2008, leading the public research consortium in the Human Genome Project (HGP). In 1998, a private company emerged that appeared to be working faster than the HGP. In the end, the public and private endeavors came together, and in 2000, Collins announced with the head of the private company that the rough draft sequence of DNA in the human genetic map had been completed. In 2003, the HGP was completed. Collins cautioned against misuse of genetic information and urged the passage of federal law to set guidelines on how individuals’ genetic information could be handled.
2 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
How has Francis Collins’ work helped medicine and biology?
Francis Collins has significantly advanced medicine and biology through his work in genetics. His discovery of genes causing genetic diseases, such as cystic fibrosis, neurofibromatosis, and Huntington chorea, has improved diagnoses and potential treatments. As the director of the National Human Genome Research Institute, Collins led the Human Genome Project, which mapped the entire human DNA sequence. This breakthrough has enabled the identification of genes associated with various diseases and the rise of personalized medicine, where treatments are tailored to an individual's genetic makeup.
2 Britannica SourcesCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles. -
What other important jobs or positions has Francis Collins held in the United States?
Francis Collins has held several prominent positions in the United States. He directed the National Human Genome Research Institute (NHGRI) at the National Institutes of Health (NIH) from 1993 to 2008. In 2009, President Barack Obama nominated him to be the director of the NIH, a position he held until 2021. During the COVID-19 pandemic in 2020, Collins was also involved in finding treatments and vaccines.
1 Britannica SourceCreated from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.
Francis Collins (born April 14, 1950, Staunton, Virginia, U.S.) is an American geneticist who discovered genes causing genetic diseases and who was director (2009–21) of the U.S. National Institutes of Health (NIH). He had previously served as head (1993–2008) of the NIH’s National Human Genome Research Institute, a public research consortium in the Human Genome Project (HGP).
Homeschooled by his mother for much of his childhood, Collins took an early interest in science. He received a B.S. degree from the University of Virginia (1970), went on to Yale University to earn an M.S. and a Ph.D. (1974), and earned an M.D. (1977) at the University of North Carolina at Chapel Hill. In 1984 Collins joined the staff of the University of Michigan at Ann Arbor as an assistant professor. His work at Michigan would earn him a reputation as one of the world’s foremost genetics researchers. In 1989 he announced the discovery of the gene that causes cystic fibrosis. The following year a Collins-led team found the gene that causes neurofibromatosis, a genetic disorder that generates the growth of tumours. He also served as a leading researcher in a collaboration of six laboratories that in 1993 uncovered the gene that causes Huntington chorea, a neurological disease.
In 1993 Collins, by then a full professor, left Michigan to become head of the National Human Genome Research Institute (NHGRI) of the NIH, which had begun work on the HGP three years earlier with a stated goal of completing the sequencing project in 15 years at a cost of $3 billion by coordinating the work of a number of leading academic research centres around the country, in collaboration with the U.S. Department of Energy and the Wellcome Trust of London. Driven by a sincere interest in successful research that could help humanity, Collins was an obvious choice for the job, and he willingly took a sizable pay cut to participate in a historic project.
The necessity of a government effort was questioned when a rival operation, Celera Genomics, emerged in 1998 and appeared to be working even faster than the HGP at deciphering the human deoxyribonucleic acid (DNA) sequence. Headed by American geneticist and businessman J. Craig Venter, a former NIH scientist, Celera had devised its own, quicker method—though some scientists, Collins among them, questioned the accuracy of the work. However, in the end the public and private endeavours came together. On June 26, 2000, Collins, Venter, and U.S. Pres. Bill Clinton gathered in Washington, D.C., to announce that the rough draft sequence of the DNA in the human genetic map had been completed through the combined effort of Collins’s public research consortium and Venter’s private company. The breakthrough was hailed as the first step toward helping doctors diagnose, treat, and even prevent thousands of illnesses caused by genetic disorders. In April 2003, following further analysis of the sequence, the HGP came to a close. The announcement of the completion of the HGP coincided with the 50th anniversary of American geneticist and biophysicist James D. Watson and British biophysicist Francis Crick’s publication on the structure of DNA.
A practicing Christian, Collins freely expressed the awe he experienced as a leader in the uncloaking of one of the mysteries of life. As concerns arose about the moral and ethical implications of the research he had conducted, Collins actively cautioned against misuse of genetic information. At congressional hearings in July 2000, Collins urged the passage of federal law to set guidelines on how individuals’ genetic information could be handled. “The potential for mischief is quite great,” he said. On August 1, 2008, Collins resigned from his position as director of the NHGRI in order to pursue broader, more flexible research opportunities.
The following year U.S. Pres. Barack Obama nominated Collins to head the NIH, and he was soon approved by the Senate. In October 2009 he was appointed by Pope Benedict XVI to the Pontifical Academy of Sciences, an organization that promotes advancement in the fundamental understanding of scientific questions and the investigation of ethical and philosophical issues associated with science. In 2020 the spread of the coronavirus disease COVID-19 was designated a pandemic, and Collins was involved in efforts to find treatments and vaccines for the disease. In October 2021 Collins announced that he would be stepping down as director of the NIH by the end of the year. He left office two months later.
In 2009 Collins published The Language of Life: DNA and the Revolution in Personalized Medicine. He also wrote several books that reflect his religious faith, notably The Language of God: A Scientist Presents Evidence for Belief (2006). His various honours included the 2020 Templeton Prize, considered by some to be the equivalent of a Nobel Prize for religion.
